An Investigational Drug Study in Healthy Adult Volunteers in a Model of Insomnia (0928-007)

MK0928 Study in Adult Patients With Primary Insomnia (0928-040)(COMPLETED)

NCT00266344 ·Status: COMPLETED ·Phase: PHASE2

Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia (0928-041)(TERMINATED)

NCT00266357 ·Status: TERMINATED ·Phase: PHASE2

Elderly Primary Insomnia Polysomnographic Study (0928-002)(TERMINATED)

NCT00094666 ·Status: TERMINATED ·Phase: PHASE3

A Study of Gaboxadol in Primary Insomnia

NCT00209924 ·Status: COMPLETED ·Phase: PHASE3

A Study of Gaboxadol in Primary Insomnia

NCT00209846 ·Status: COMPLETED ·Phase: PHASE3

Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED)

NCT00420810 ·Status: TERMINATED ·Phase: PHASE3

A Prospective Active-Reference Study of Gaboxadol in Primary Insomnia

NCT00209937 ·Status: COMPLETED ·Phase: PHASE3

A Study of Gaboxadol in Primary Insomnia

NCT00209963 ·Status: COMPLETED ·Phase: PHASE3

Polysomnography Study of MK-6096 in Participants With Primary Insomnia (MK-6096-011)

NCT01021852 ·Status: COMPLETED ·Phase: PHASE2

A Prospective Open-Label Extension Study of Gaboxadol in Primary Insomnia

NCT00209950 ·Status: COMPLETED ·Phase: PHASE3

Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia

NCT00280423 ·Status: COMPLETED ·Phase: PHASE2

An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia

NCT03338764 ·Status: WITHDRAWN ·Phase: PHASE3

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-48816274

NCT02852395 ·Status: COMPLETED ·Phase: PHASE1

To Evaluate The Effects Of SB-649868 (10, 30 Mg And 60 Mg) On Subjects With Primary Insomnia

NCT00426816 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Efficacy, Safety and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder Without Psychiatric Comorbidity

NCT02464046 ·Status: COMPLETED ·Phase: PHASE2

A Long Term Safety Study of Suvorexant in Participants With Primary Insomnia (MK-4305-009 AM3)

NCT01021813 ·Status: COMPLETED ·Phase: PHASE3

Phase IIB 2-Period Crossover Polysomnography Study in Participants With Primary Insomnia (MK-4305-006)

NCT00792298 ·Status: COMPLETED ·Phase: PHASE2

Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia

NCT00280436 ·Status: COMPLETED ·Phase: PHASE2

Suvorexant and Trauma Related Insomnia

NCT02704754 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder

NCT02841709 ·Status: COMPLETED ·Phase: PHASE2

A Dose-ranging, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia

NCT00551148 ·Status: COMPLETED ·Phase: PHASE2

Appraising Clinical Trial Experiences of Patients With Insomnia

NCT05978271 ·Status: NOT_YET_RECRUITING

Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia

NCT00354809 ·Status: COMPLETED ·Phase: PHASE2

A Study to Investigate The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP441 in Sleep-deprived Healthy Participants

NCT05651152 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Safety of Gabapentin in a Potential Over-the-Counter Population With Occasional Sleeplessness

NCT00666575 ·Status: COMPLETED ·Phase: PHASE3